[1]
|
Furness, J.B., Kunze, W.A. and Clerc, N. (1999) Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. American Journal of Physiology, 277, 922-928.
|
[2]
|
Borriello, S.P. and Barclay, F.E. (1986) An in-vitro model of colonisation resistance to Clostridium difficile infection. Journal of Medical Microbiology, 21, 299-309.
doi:10.1099/00222615-21-4-299
|
[3]
|
Borriello, S.P. (1990) The influence of the normal flora on Clostridium difficile colonisation of the gut. Annals of Medicine, 22, 61-7. doi:10.3109/07853899009147244
|
[4]
|
Isakow, W., Morrow, L.E. and Kollef, M.H. (2007) Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest, 132, 286-294. doi:10.1378/chest.06-2156
|
[5]
|
Garibaldi, R.A. (1999) Residential care and the elderly: the burden of infection. Journal of Hospital Infection, 43, supplement, S9-18. doi:10.1016/S0195-6701(99)90061-0
|
[6]
|
Makris, A.T. and Gelone, S. (2007) Clostridium difficile in the long-term care setting. Journal of the American Medical Directors Association, 8, 290-299.
doi:10.1016/j.jamda.2007.01.098
|
[7]
|
Gao, X.W., Mubasher, M., Fang, C.Y., Reifer, C. and Miller, L.E. (2010) Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. The American Journal of Gastroenterology, 105, 1636-1641.
doi:10.1038/ajg.2010.11
|
[8]
|
Katz, J.A. (2006) Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. Journal of Clinical Gastroenterology, 40, 249-255.
doi:10.1097/00004836-200603000-00017
|
[9]
|
Pochapin, M. (2000) The effect of probiotics on Clostridium difficile diarrhea. American Journal of Gastroenterology, 95, S11-S13.
doi:10.1016/S0002-9270(99)00809-6
|
[10]
|
Bartlett, J.G., Chang, T.W. Gurwith, M., Gorbach, S.L. and Onderdonk, A.B. (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. The New England Journal of Medicine, 298, 531-534.
doi:10.1056/NEJM197803092981003
|
[11]
|
Bartlett, J.G., Willey, S.H., Chang, T.W. and Lowe, B. (1979) Cephalosporin-associated pseudomembranous colitis due to Clostridium difficile. The Journal of the American Medical, 242, 2683-2685.
doi:10.1001/jama.242.24.2683
|
[12]
|
Ricciardi, R., Rothenberger, D.A., Madoff R.D., and Baxter, N.N. (2007) Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Archives of Surgery, 142, 624-631.
doi:10.1001/archsurg.142.7.624
|
[13]
|
Fekety, R. (1997) Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis, American College of Gastroenterology, Practice Parameters Committee. American Journal of Gastroenterology, 92, 739-750.
|
[14]
|
Aslam, S., Hamill, R.J. and Musher, D.M. (2005) Treatment of Clostridium difficile-associated disease: old therapies and new strategies. The Lancet Infectious Diseases, 5, 549-557. doi:10.1016/S1473-3099(05)70215-2
|
[15]
|
Gerding, D.N., Muto, C.A. and Owens Jr., R.C. (2008) Treatment of Clostridium difficile infection. Clinical Infectious Diseases, 46, supplement, 32-S42.
doi:10.1086/521860
|
[16]
|
Halsey, J. (2008) Current and future treatment modalities for Clostridium difficile-associated disease. American Journal of Health-System Pharmacy, 65, 705-715.
doi:10.2146/ajhp070077
|
[17]
|
Musher, D.M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F. and Hamill, R.J. (2005) Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clinical Infectious Diseases, 40, 1586-1590. doi:10.1086/430311
|
[18]
|
Gerding, D.N., Johnson, S., Peterson, L.R., Mulligan, M.E. and Silva Jr., J. (1995) Clostridium difficile-associated diarrhea and colitis. Infection Control and Hospital Epidemiology, 16, 459-477.
doi:10.1086/648363
|
[19]
|
Pepin, J., Valiquette, L., Alary, M.E., Villemure, P., Pelletier, A., Forget, K., Pepin, K. and Chouinard, D. (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Canadian Medical Association Journal, 171, 466-472.
|
[20]
|
Plummer, S., Weaver, M.A., Harris, J.C., Dee, P. and Hunter, J. (2004) Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhea. International Microbiology, 7, 59-62.
|
[21]
|
Hedge, D.D., Strain, J.D., Heins, J.R. and Farver, D.K. (2008) New advances in the treatment of Clostridium difficile infection (CDI). Journal of Therapeutics and Clinical Risk Management, 4, 949-964.
|
[22]
|
Barbut, F. and Petit, J.C. (2001) Epidemiology of Clostridium difficile-associated infections. Clinical Microbiology and Infection, 7, 405-410.
doi:10.1046/j.1198-743x.2001.00289.x
|
[23]
|
Surawicz, C.M., Elmer, G.W., Speelman, P., McFarland, L.V., Chinn, J. and van Belle, G. (1989) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology, 96, 981-988.
|
[24]
|
McFarland, L.V., Surawicz, C.M., Greenberg, R.N., Elmer, G.W., Moyer, K.A. Melcher, S.A., Bowen, K.E. and Cox, J.L. (1995) Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. American Journal of Gastroenterology, 90, 439-448.
|
[25]
|
Can, M., Besirbellioglu, B.A., Avci, I.Y., Beker, C.M. and Pasha, A. (2006) Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Medical Science Monitor, 2, 19-22.
|
[26]
|
Surawicz, C.M., McFarland, L.V., Elmer, G. and Chinn, J. (1989) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. American Journal of Gastroenterology, 84. 1285-1287.
|
[27]
|
McFarland, L.V., Surawicz, C.M., Greenberg, R.N., Fekety, R.G., Elmer, W., Moyer, K.A., Melcher, S.A. Bowen, K.E., Cox, J.L., Noorani, Z., Harrington, G., Rubin, M. and Greenwald, D. (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. The Journal of the American Medical, 271, 1913-1918. doi:10.1001/jama.271.24.1913
|
[28]
|
Surawicz, C.M., McFarland, L.V., Greenberg, R.N., Rubin, M., Fekety, R., Mulligan, M.E., Garcia, R.J., Brandmarker, S., Bowen, K., Borjal, D. and Elmer, G.W. (2000) The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clinical Infectious Diseases, 31, 1012-1017. doi:10.1086/318130
|
[29]
|
McFarland, L.V. (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology, 101, 812-822.
doi:10.1111/j.1572-0241.2006.00465.x
|
[30]
|
Szajewska, H. and Mrukowicz, J. (2005) Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea. Alimentary Pharmacology and Therapeutics, 22, 365-372.
doi:10.1111/j.1365-2036.2005.02624.x
|
[31]
|
Buts, J.P., De Keyser, N. and De Raedemaeker, L. (1994) Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatric Research, 36, 522-527.
doi:10.1203/00006450-199410000-00019
|
[32]
|
Qamar, A., Aboudola, S., Warny, M., Mitchetti, P., Pothoulakis, C., Lamont, J.T. and Kelly, C.P. (2001) Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infection and Immunity, 69, 2762-2765.
doi:10.1128/IAI.69.4.2762-2765.2001
|
[33]
|
Castagliuolo, I., LaMont, J.T., Nikulasson, S.T. and Pothoulakis, C. (1996) Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infection and Immunity, 64, 5225- 5232.
|
[34]
|
Castagliuolo, I., Riegler, M.F., Valenick, L., LaMont, J.T. and Pothoulakis, C. (1993) Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infection and Immunity, 67, 302-307.
|
[35]
|
Pothoulakis, C., Kelly, C.P., Joshi, M.A., Gao, N., O'Keane, C.J., Castagliuolo, I. and LaMont, J.T. (1993) Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology, 104, 1108-15.
|
[36]
|
Chen, X., Kokkotou, E.G., Mustafa, N., Bhaskar, K.R., Sougioltzis, S., O'Brein, M., Pothoulakis, C. and Kelly, C.P. (2006) Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. The Journal of Biological Chemistry, 281, 24449-24454.
doi:10.1074/jbc.M605200200
|
[37]
|
Sougioultzis, S., Simeonidis, S., Bhaskar, K.R., Chen, X., Anton, P.M., Keates, S., Pothoulakis, C. and Kelly, C.P. (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochemical and Biophysical Research Communications, 343, 69-76.
doi:10.1016/j.bbrc.2006.02.080
|
[38]
|
La Rosa, M., Bottaro, G., Gulino, N., Gambuzza, F., DiForti, F., Ini, G. and Tornambe, E. (2003) Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study. Minerva Pediatrica, 55, 447-452.
|
[39]
|
Gibson, G.R., Beatty, E.R., Wang, X. and Cummings, J.H. (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology, 108, 975-982. doi:10.1016/0016-5085(95)90192-2
|
[40]
|
Losada, M.A. and Olleros, T. (2002) Towards a healthier diet for the colon: the influence of fructooligosaccharides and lactobacilli on intestinal health. Nutrition research, 22, 71-84. doi:10.1016/S0271-5317(01)00395-5
|
[41]
|
Garleb, K., Snowden, M., Wolf, B. and Chow, J. (2002) Application of fructooligosaccharides to medical foods as fermentable dietary fiber. Bioscience and Microflora, 21, 43-54.
|
[42]
|
Doron, S.I., Hibberd, P.L. and Gorbach, S.L. (2008) Probiotics for prevention of antibiotic-associated diarrhea. Journal of Clinical Gastroenterology, 42, supplement 2, S58-S63. doi:10.1097/MCG.0b013e3181618ab7
|